Literature DB >> 10391612

Inhaled nitric oxide does not alter pulmonary or cardiac effects of fat embolism in dogs after cemented arthroplasty.

R J Byrick1, J B Mullen, P M Murphy, J C Kay, T E Stewart, G Edelist.   

Abstract

PURPOSE: We examined the effect of inhaled nitric oxide (NO) on the acute pulmonary hypertension and right ventricular (RV) dilation after fat embolism.
METHODS: A bilateral cemented arthroplasty (BCA), created fat embolism in 20 dogs. In Part A, 12 dogs were randomized to an NO group (n=6, inhaled NO 40 ppm before BCA and throughout the study) or a control group (n=6). In Part B, a third group of dogs (n=8) were given NO 20-40 ppm 2-3 min after BCA when pulmonary artery pressure (PAP) increased. Transesophageal echocardiography (TEE) and invasive hemodynamic monitoring evaluated the hemodynamic response to BCA. Postmortem, quantitative morphometry was used to estimate the number of fat emboli and diameter of lung vessel occluded by fat.
RESULTS: Part A: The increase in PAP in the NO group (16 +/- 1 to 34 +/- 9 mmHg) within three minutes of BCA was not different from that in the control group (14 +/- 4 to 35 +/- 9 mmHg). Within three minutes of BCA, TEE demonstrated RV dilation in all groups (P < 0.05) but there was no difference in the change in RV area in the NO and control groups. When NO was given after BCA, no difference in PAP or RV dilation was noted from that in the control group. There were no differences, at post mortem, between the groups in the diameter of lung vessel occluded by fat
CONCLUSION: Whether given before the embolic insult or two to three minutes after the onset of pulmonary hypertension, inhaled NO did not attenuate the acute pulmonary hypertension or RV dilation after cemented arthroplasty.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10391612     DOI: 10.1007/BF03013555

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  2 in total

1.  The effect of a combination of inhaled nitric oxide and an endothelinA-receptor antagonist on hemodynamic dysfunction in experimental acute pulmonary thromboembolism.

Authors:  Ji-Hyun Lee; Sehyun Kim; Byung-Kyu Park; Woo-Sung Kim; Dong-Soon Kim; Won-Dong Kim; Sang-Do Lee
Journal:  Lung       Date:  2005 Mar-Apr       Impact factor: 2.584

2.  Reversible catastrophic fat embolism: a case report.

Authors:  Kethy Jules-Elysee; Thomas P Sculco
Journal:  HSS J       Date:  2006-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.